Investigative reporter Gary Weiss takes a look at the procedures related to credit card arbitration -- the way that consumers are forced to resolve disputes they have with issuers in his latest 'Muckraker' column for Forbes. The problem, writes Weiss, is that the National Arbitration Forum that resolves these disputes is hopelessly stacked against the consumer. He writes that "Mandatory arbitration clauses, which are widely criticized for preventing brokerage customers from having their day in court, have metastasized to ordinary credit card agreements. This has resulted in inequities and injustices that makes securities arbitration seem like a fairyland of justice by comparison."
It's hard to imagine what exactly the justification for this arbitration system is -- particularly given that consumers have no choice. Why is the legal system provided for citizens under the Constitution that has worked reasonably well throughout our history inadequate for the credit card and brokerage industries?
Another recent study shows the unfairness of the arbitration system in the brokerage industry. It seems that brokers found to have engaged in malpractice routinely have their records expunged without any kind of hearing! Of course this makes background checks with the NASD for complaints relatively useless.
Senator Russ Feingold has introduced a bill that would ban mandatory arbitration clauses in employment, consumer, and franchise disputes, and Weiss believes it should be expanded to include brokerage disputes.
But of course the bill is likely to be nixed by the financial services industry's lobby -- and of course Average Joe consumers don't have a lobby. They sleep in the lobby.
Last updated: February 13, 2012: 08:24 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
TheFlyOnTheWall.com Headlines
- Chesapeake Energy volatility flat at 42 into financial plan
- Gardner Denver shares attractive at current levels, says RBC Capital
- Parkway Properties completes purchase of Phoenix Asset
- Total Q4 results in-line with expectations, says Nomura
- Mattress Firm downgraded to Market Perform from Outperform at Raymond James
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
10-13-2007 @ 7:00AM
hal c said...
I read Weiss's blog every day. I do wish he would spend less time being obsessed with bashing Overstock.com and concentrate more on issues like the one in this blog. Gary, you've made your point. Give it a break for God's sake. You're wasting your talent.